Brigit Biofarmaka Teknologi Tbk. vs Tirta Mahakam Resources Tbk — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Tirta Mahakam Resources Tbk trades at Rp590 (market cap 657.65B, 520K 24h volume). The key difference: Tirta Mahakam Resources Tbk is far larger — about 4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Tirta Mahakam Resources Tbk is more actively traded (520K versus 324K). Which is the better fit depends on your goals.
| OBAT | TIRT | |
|---|---|---|
Market Cap | 166.01B | 657.65B |
Volume | 324K | 520K |
Lot | 3.24K | 5.2K |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Tirta Mahakam Resources Tbk (The Company) was established based on Deed No. 245 dated April 22, 1981 jo. Revision deed No. 14 dated January 11, 1982, both of which were made in front of Notary Kartini Muljadi, SH. The Company started its commercial production in November 1983. The Companys domicilie is in South of Jakarta with its factories in Samarinda, East Kalimantan.
Read more on TIRT →